Back to Journals » Drug Design, Development and Therapy
Drug Design, Development and Therapy
Editor-in-Chief: Professor Frank Boeckler
An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (5689)
- Volume 20, 2026 (458)
- Volume 19, 2025 (762)
- Volume 18, 2024 (430)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Latest articles:
- 5 records -
Metformin Sensitizes HR+/HER2- Breast Cancer Cells to CDK4/6 Inhibitor via Suppressing of PI3K/AKT/mTOR Signaling Pathway
Zhu L, Yang J, Li F, Wang D, Zhang W, Zhang J, Duan Z, Hu Y, Zhou Y
Drug Design, Development and Therapy 2026, 20:544583
Published Date: 3 July 2026
The Median Effective Infusion Rate of Ciprofol with Different Doses of Esketamine During Gastrointestinal Endoscopy: A Randomized Controlled Trial
Tang SH, Bao SY, He YY, Ding T, Zhang H, Song JC
Drug Design, Development and Therapy 2026, 20:557205
Published Date: 3 July 2026
Donidalorsen for the Treatment of Hereditary Angioedema: A Review of Clinical Studies
Riedl MA, Craig T, Lumry WR, Bordone L, Treadwell S, Yarlas A, Newman KB, Cohn DM
Drug Design, Development and Therapy 2026, 20:589693
Published Date: 3 July 2026
Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study
Qiao H, Liu X, Nan H, Zhang M, Bai Y, Zhou K, Zhang X
Drug Design, Development and Therapy 2026, 20:607574
Published Date: 3 July 2026
The Optimal Dose of Butorphanol Combined with Ropivacaine for Supraclavicular Brachial Plexus Block in Patients Undergoing Upper Limb Fracture Surgery: A Randomized, Double-Blind, Controlled Clinical Trial
Gao X, Wei Q, Peng J, Xu H, Fu W, Wang F
Drug Design, Development and Therapy 2026, 20:610539
Published Date: 3 July 2026